Premium
InNexus Biotechnology Inc (CE) (IXSBF)
USOTC
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
-- Key Data are New Releases for the Company Building on Milestones with Recent FDA Meetings and Technology Discoveries -- DENVER, April 20 /PRNewswire-FirstCall/ -- DXL625 monoclonal antibodies...
- Additional Presentations Underscore Potency, Binding Capabilities for Antibody Pipeline And Novel Technologies - SCOTTSDALE, Ariz., April 9 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc...
BRITISH COLUMBIA, Canada, March 25 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com/), a drug development company...
- Company Receives Allowance of Patent Claims in the U.S. and in India - BRITISH COLUMBIA, Canada, March 6 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc. (OTC Bulletin Board: IXSBF; TSX...
- Agency Supports Company's Production and Clinical and Preclinical Plans for DXL625 - BRITISH COLUMBIA, Canada March 3 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc. (Toronto Stock...
BRITISH COLUMBIA, Canada, Jan. 27 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc. (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com/), announced today that it has...
BRITISH COLUMBIA, Canada, Jan. 13 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com/), a drug development company...
BRITISH COLUMBIA, Canada, Nov. 17 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com/), a drug development company...
- Innovative Biotech Targets Another Large Well-Known Product and Continues Expansion of Antibody Therapeutics Pipeline - BRITISH COLUMBIA, Canada, Nov. 7 /PRNewswire-FirstCall/ -- InNexus...
- CEO Morhet to Discuss Continued Expansion of DXL(TM) Patent Protection at 7th Annual BIO Investor Forum - BRITISH COLUMBIA, Canada, Oct. 30 /PRNewswire-FirstCall/ -- InNexus Biotechnology...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | -9.9E-5 | -99 | 0.0001 | 0.0001 | 1.0E-6 | 26064 | 7.994E-5 | CS |
| 156 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 171680 | 9.013E-5 | CS |
| 260 | -9.0E-6 | -90 | 1.0E-5 | 0.0002 | 1.0E-6 | 100135 | 5.459E-5 | CS |
| Symbole | Prix | Vol. |
|---|---|---|
| GMPRGourmet Provisions International Corporation (PK) | US$ 0,0001 (-33,33%) | 437,02M |
| KGKGKona Gold Beverage Inc (PK) | US$ 0,0006 (0,00%) | 201,47M |
| HIRUHiru Corporation (PK) | US$ 0,0032 (-21,95%) | 151,12M |
| SIRCSolar Integrated Roofing Corporation (PK) | US$ 0,0001 (0,00%) | 105,17M |
| HMBLHUMBL Inc (PK) | US$ 0,00025 (25,00%) | 100,46M |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
